Recent Top Projects
Bench International Leaders of Leaders
We are honored to have been entrusted with vital leadership roles that have had significant impacts on the boards and businesses they serve, with a representative list below.
Cardiff Oncology
Independent Director (2)
Carina Biotech
Independent Director (2)
Fate Therapeutics
Independent Director
Histogen
Independent Director (2)
Illumina
Independent Director (3)
Ethics Advisory Board
Mammogen
Independent Director
Pliant Therapeutics
Independent Director (2)
SioGene Therapies
Independent Director
Vaxxinity
Independent Director
Cardiff Oncology – Independent Director (2)
Carina Biotech – Independent Director (2)
Fate Therapeutics – Independent Director
Histogen – Independent Director (2)
Illumina – Independent Director (3), Ethics Advisory Board
Mammogen – Independent Director
Pliant Therapeutics – Independent Director (2)
SioGene Therapies -Independent Director
Vaxxinity – Independent Director
Alexion
Chief Medical Officer
Alovant
President and Chief Operating Officer
Ascensia
Chief Medical Officer
Aviwell
Chief Executive Officer & Director
Bexion Pharmaceuticals
Chief Executive Officer & Director
Chief Financial Officer
BioLA
Chief Executive Officer
Brickell Biotech
Chief Medical Officer
Cardiff Oncology
Chief Scientific Officer
Cellectis
Chief Medical Officer
Cellics
Chief Executive Officer & Director
Confidential
Chief Financial Officer
Corsair
Chief Executive Officer
Critical Path Institute
Chief Executive Officer & Director
Dermavant Sciences
Chief Scientific Officer
Engrail
CSO and SVP of Development
Exciva
Chief Executive Officer & Director
Fate Therapeutics
Chief Medical Officer
Gallant
Chief Executive Officer & Director
Glenmark
Chief Commercial Officer
Halozyme
Chief Operations Officer
Imagion
Chief Development Officer
Inivata, Inc.
Chief Medical Officer
LabCentral
Chief People Officer
Lineage Cell Therapeutics
Chief Executive Officer & Director
Mammogen
Chief Executive Officer & Director
Neuraptive
Chief Operating Officer and EVP, Head of R&D
New Rhein
Managing Partner & Chief Medical Officer
Onchilles
Chief Scientific Officer
Pierian
Chief Executive Officer & Director
Poseida
President, Gene Therapy
President, Cell Therapy
Sanofi
Chief Patient Officer
Symbio Pharmaceuticals
Chief Executive Officer
United Bomedical
EVP, Research & Development
United Neuroscience
Chief Scientific Officer
Valavant
Chief Executive Officer & Director
Alexion – Chief Medical Officer
Alovant – President and Chief Operating Officer
Ascensia – Chief Medical Officer
Aviwell – Chief Executive Officer & Director
Bexion Pharmaceuticals – Chief Executive Officer & Director, Chief Financial Officer
BioLA – Chief Executive Officer
Brickell Biotech – Chief Medical Officer
Cardiff Oncology – Chief Scientific Officer
Cellectis – Chief Medical Officer
Cellics – Chief Executive Officer & Director
Confidential – Chief Financial Officer
Corsair – Chief Executive Officer
Critical Path Institute – Chief Executive Officer & Director
Dermavant Sciences – Chief Scientific Officer
Engrail – CSO and SVP of Development
Exciva – Chief Executive Officer & Director
Fate Therapeutics – Chief Medical Officer
Gallant – Chief Executive Officer & Director
Glenmark – Chief Commercial Officer
Imagion – Chief Development Officer
Inivata, Inc. – Chief Medical Officer
LabCentral – Chief People Officer
Lineage Cell Therapeutics – Chief Executive Officer & Director
Mammogen – Chief Executive Officer & Director
Neuraptive – Chief Operating Officer and EVP, Head of R&D
New Rhein – Managing Partner & Chief Medical Officer
Onchilles – Chief Scientific Officer
Pierian – Chief Executive Officer & Director
Poseida – President, Gene Therapy & President, Cell Therapy
Sanofi – Chief Patient Officer
Symbio Pharmaceuticals – Chief Executive Officer
United Bomedical – EVP, Research & Development
United Neuroscience – Chief Scientific Officer
Valavant – Chief Executive Officer & Director
3T Biosciences
Head of Finance
Accent Therapeutics
Head of Biology
Adaptimmune
VP, Clinical Development
Advaxis
VP, Medical
Alexion
SVP, Medical Affairs
Country Leader
VP, Clinical Development Neurology
VP, Quality Operations
Almatica
VP, Regulatory Affairs
Amicus
SVP, Clinical Research, Gene Therapy
Global Head of Medical Affairs
Ascensia
Global Head, Clinical Development & Operations
Atyr
VP, Regulatory Affairs
Bayer Healthcare
Therapeutic Head, Cardiovascular
Head of Development Center, Skincare
Country Head France, BAH
Pricing Market Access EU
Becton Dickinson
VP, Medical Affairs (4)
Beigene
SVP, Global Head Business Development
VP, Alliance Project
VP, Global Clinical Operations
VP, Head of Europe Medical Affairs
VP, Head of Late Stage Development
Blueprint Medicines
VP, Biology
VP, Translational Medicine
Cardiff Oncology Inc.
SVP, Regulatory Affairs
Cellectis
SVP, Regulatory Affairs
Clovis
VP, Safety & Pharmacovigilance
Embecta (subsidiary of BD)
Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer
EyePoint Pharmaceuticals
Senior VP, Program Leadership
Fate Therapeutics
SVP, Corporate Development
SVP, Technical Operations
VP, Clinical Development (3)
VP, Solid Tumor Biology
Glenmark
VP, Market Access
Humacyte Inc.
VP, Scientific & Medical Communications
Idorsia
Clinical Lead – Neurology
Insmed
SVP, Head of Clinical Development
Intellectual Ventures
Commercial Lead, Medical Technologies
Intercept
VP, Regulatory Affairs, R&D
Jasper Therapeutics
VP, Clinical Operations
Johnson & Johnson
VP, Biologics Discovery
Head, J&J Innovation West NA, Australia & New Zealand
LabCentral
Executive Director, Ignite
Myovant
SVP, Pharma. Operations and Development
Nutrinia
VP, Regulatory Affairs
Pfizer
VP, Development Head
Immuno-Oncology Medicine Team Lead
Pharma Essentia
Global Head of Pharmacovigilance
Regeneron
Global Program Head – Oncology
VP, Strategic Program Direction TA Head, Oncology
VP, Global Program Head Immunology
Strategic Program Director, CV/META
Strategic Program Heads (2)
Regulus
VP, Preclinical Development
Sanofi
Head of Bioprocesses
Symbio Pharmaceuticals
SVP R&D and Global Chief Medical Officer
Talis BioMedical
VP, Assay Development
Urovant
VP, Manufacturing
VP, Regulatory Affairs & Quality Assurance
VP, Manufacturing
Urovant
VP, Manufacturing
Zymeworks
SVP, Research
3T Biosciences – Head of Finance
Accent Therapeutics – Head of Biology
Adaptimmune -VP, Clinical Development
Advaxis – VP, Medical
Alexion – SVP, Medical Affairs, Country Leader, VP, Clinical Development Neurology, VP, Quality Operations
Almatica – VP, Regulatory Affairs
Amicus – SVP, Clinical Research, Gene Therapy, Global Head of Medical Affairs
Ascensia – Global Head, Clinical Development & Operations
Atyr – VP, Regulatory Affairs
Bayer Healthcare – Therapeutic Head, Cardiovascular, Head of Development Center, Skincare, Country Head France, BAH, Pricing Market Access EU
Embecta (subsidiary of BD) – Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer
Becton Dickinson – VP, Medical Affairs (4)
Beigene – SVP, Global Head Business Development, VP, Alliance Project, VP, Global Clinical Operations, VP, Head of Europe Medical Affairs, VP, Head of Late Stage Development
Blueprint Medicines – VP, Biology, VP, Translational Medicine
Cardiff Oncology Inc. – SVP, Regulatory Affairs
Cellectis – SVP, Regulatory Affairs
Clovis – VP, Safety & Pharmacovigilance
EyePoint Pharmaceuticals – Senior VP, Program Leadership
Fate Therapeutics – SVP, Corporate Development, SVP, Technical Operations, VP, Clinical Development (3), VP, Solid Tumor Biology
Glenmark – VP, Market Access
Humacyte Inc. – VP, Scientific & Medical Communications
Idorsia – Clinical Lead – Neurology
Insmed – SVP, Head of Clinical Development
Intellectual Ventures – Commercial Lead, Medical Technologies
Intercept- VP, Regulatory Affairs, R&D
Jasper Therapeutics – VP, Clinical Operations
Johnson & Johnson – VP, Biologics Discovery, Head, J&J Innovation West NA, Australia & New Zealand
LabCentral – Executive Director, Ignite
Myovant – SVP, Pharma. Operations and Development
Nutrinia – VP, Regulatory Affairs
Pfizer – VP, Development Head, Immuno-Oncology Medicine Team Lead
Pharma Essentia – Global Head of Pharmacovigilance
Regeneron – Global Program Head – Oncology, VP, Strategic Program Direction TA Head, Oncology, VP, Global Program Head Immunology, Strategic Program Director, CV/META, Strategic Program Heads (2)
Regulus – VP, Preclinical Development
Sanofi – Head of Bioprocesses
Symbio Pharmaceuticals – SVP R&D and Global Chief Medical Officer
Talis BioMedical – VP, Assay Development
Urovant – VP, Manufacturing
Xencor – VP, Regulatory Affairs & Quality Assurance
Zymeworks – SVP, Research
We make life-changing placements so our clients can change lives!®
©2024 BENCH INTERNATIONAL SEARCH, INC. ALL RIGHTS RESERVED.
Website Accessibility | Privacy Notice | Sitemap